Mutual of America Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.26M | Sell |
16,795
-1,013
| -6% | -$65.1K | 0.01% | 945 |
|
|
2026
Q1 | $1M | Sell |
17,808
-1,673
| -9% | -$109K | 0.01% | 948 |
|
|
2025
Q4 | $1.56M | Sell |
19,481
-2,769
| -12% | -$186K | 0.02% | 883 |
|
|
2025
Q3 | $1.08M | Sell |
22,250
-2,733
| -11% | -$169K | 0.01% | 966 |
|
|
2025
Q2 | $1.86M | Sell |
24,983
-872
| -3% | -$57.7K | 0.02% | 836 |
|
|
2025
Q1 | $1.64M | Sell |
25,855
-676
| -3% | -$46K | 0.02% | 891 |
|
|
2024
Q4 | $2.07M | Sell |
26,531
-1,130
| -4% | -$90.8K | 0.02% | 841 |
|
|
2024
Q3 | $2.22M | Sell |
27,661
-1,418
| -5% | -$115K | 0.02% | 857 |
|
|
2024
Q2 | $2.41M | Sell |
29,079
-1,180
| -4% | -$104K | 0.03% | 801 |
|
|
2024
Q1 | $2.58M | Sell |
30,259
-1,106
| -4% | -$86.8K | 0.03% | 798 |
|
|
2023
Q4 | $2.68M | Sell |
31,365
-1,612
| -5% | -$139K | 0.03% | 767 |
|
|
2023
Q3 | $2.95M | Sell |
32,977
-3,444
| -9% | -$307K | 0.04% | 680 |
|
|
2023
Q2 | $3.1M | Sell |
36,421
-4,177
| -10% | -$353K | 0.04% | 715 |
|
|
2023
Q1 | $3.36M | Sell |
40,598
-983
| -2% | -$79.6K | 0.04% | 687 |
|
|
2022
Q4 | $3.27M | Buy |
41,581
+355
| +0.9% | +$28.5K | 0.04% | 681 |
|
|
2022
Q3 | $3.05M | Sell |
41,226
-1,509
| -4% | -$108K | 0.04% | 646 |
|
|
2022
Q2 | $2.79M | Sell |
42,735
-3,878
| -8% | -$230K | 0.04% | 729 |
|
|
2022
Q1 | $2.95M | Buy |
46,613
+906
| +2% | +$49.3K | 0.03% | 799 |
|
|
2021
Q4 | $2.42M | Buy |
45,707
+771
| +2% | +$47K | 0.02% | 909 |
|
|
2021
Q3 | $3.17M | Buy |
44,936
+680
| +2% | +$42.9K | 0.03% | 764 |
|
|
2021
Q2 | $2.95M | Sell |
44,256
-1,549
| -3% | -$110K | 0.03% | 806 |
|
|
2021
Q1 | $5.08M | Sell |
45,805
-1,480
| -3% | -$183K | 0.05% | 490 |
|
|
2020
Q4 | $5.62M | Sell |
47,285
-388
| -0.8% | -$41.8K | 0.06% | 406 |
|
|
2020
Q3 | $4.16M | Sell |
47,673
-32,211
| -40% | -$2.82M | 0.06% | 454 |
|
|
2020
Q2 | $7.15M | Buy |
79,884
+12,161
| +18% | +$1.23M | 0.1% | 211 |
|
|
2020
Q1 | $6.75M | Buy |
67,723
+629
| +0.9% | +$68.2K | 0.11% | 192 |
|
|
2019
Q4 | $7.71M | Buy |
67,094
+289
| +0.4% | +$35K | 0.1% | 238 |
|
|
2019
Q3 | $8.43M | Buy |
66,805
+20,871
| +45% | +$2.65M | 0.12% | 187 |
|
|
2019
Q2 | $5.53M | Buy |
45,934
+286
| +0.6% | +$28.1K | 0.08% | 349 |
|
|
2019
Q1 | $3.99M | Sell |
45,648
-559
| -1% | -$50.8K | 0.06% | 519 |
|
|
2018
Q4 | $4.62M | Sell |
46,207
-11,634
| -20% | -$1.22M | 0.08% | 365 |
|
|
2018
Q3 | $6.63M | Sell |
57,841
-1,497
| -3% | -$155K | 0.09% | 269 |
|
|
2018
Q2 | $5.32M | Buy |
+59,338
| New | +$5.01M | 0.08% | 358 |
|
Other funds holding HAE
AI
Mutual of America Capital Management's HAE Position: Q2 2026 in Review
Mutual of America Capital Management reduced its Haemonetics (HAE) stake by 5.7% in Q2 2026, selling an estimated $65.1K and leaving 16,795 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #945.
Mutual of America Capital Management first reported a position in HAE in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.43M in Q3 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Mutual of America Capital Management held 16,795 shares of Haemonetics worth $1.26M as of Q2 2026.
- Mutual of America Capital Management sold 1,013 Haemonetics shares in Q2 2026, an estimated $65.1K.
- Haemonetics made up 0.01% of Mutual of America Capital Management's portfolio in Q2 2026, its #945 holding.
- Mutual of America Capital Management first reported a position in Haemonetics in Q2 2018 and has held it in 33 quarters since.
- Mutual of America Capital Management's Haemonetics position peaked at $8.43M in Q3 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.